Clinical Trials Browser

Lymphoma, T-Cell × duvelisib × 90 days × Clear all

NCT04331119 2025-12-30

Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas

Phase 2 Active not recruiting

Lymphoma, T-Cell